Regional Distribution & Vector Identification
Clinical Classification of Pathogens
| Class | Pathogen(s) | Primary Vector(s) |
|---|---|---|
| Bacteria — Spirochete | Borrelia burgdorferi, Borrelia mayonii | Ixodes scapularis, Ixodes pacificus |
| Bacteria — Obligate Intracellular | Anaplasma phagocytophilum, Ehrlichia chaffeensis, Rickettsia rickettsii | Ixodes spp., Amblyomma americanum, Dermacentor spp. |
| Bacteria — Gram-Negative Coccobacillus | Francisella tularensis | Dermacentor spp., Amblyomma americanum |
| Protozoan Parasite | Babesia microti | Ixodes scapularis |
| Virus | Powassan virus, Heartland virus, Bourbon virus, Colorado Tick Fever virus | Ixodes spp., Amblyomma americanum, Dermacentor spp. |
Clinical Data, Presentation & Diagnostics
Lyme Disease
Rocky Mountain Spotted Fever (RMSF)
Anaplasmosis & Ehrlichiosis
Babesiosis
Powassan Virus Encephalitis
Pharmacological Treatment Guide
First-Line: Doxycycline
Adult dose: 100 mg PO or IV twice daily
Duration — Lyme (early localized): 10–14 days
Duration — Lyme (disseminated/arthritis): 14–21 days (oral); neurological Lyme: 14–28 days IV ceftriaxone
Duration — RMSF, Anaplasmosis, Ehrlichiosis: Minimum 7 days, continue at least 3 days after defervescence
Pediatric dose: 2.2 mg/kg per dose twice daily (max 100 mg per dose)
Doxycycline is first-line for RMSF in children of all ages — short courses (≤21 days) do not cause clinically significant dental staining.
Lyme Disease Alternatives (Pregnancy or Tetracycline Allergy)
Cefuroxime axetil: 500 mg PO twice daily × 14–21 days
Note: Neither amoxicillin nor cefuroxime is effective for RMSF, Anaplasmosis, or Ehrlichiosis.
Babesiosis
Atovaquone 750 mg PO BID + Azithromycin 500 mg PO day 1, then 250 mg daily × 7–10 days
Severe / Immunocompromised:
Clindamycin 600 mg IV TID (or 300–600 mg PO TID) + Quinine 650 mg PO TID × 7–10 days
Consider exchange transfusion for parasitemia >10%, severe hemolysis, or cardiopulmonary compromise.
Viral Tick-Borne Diseases (Powassan, Heartland, Bourbon, Colorado Tick Fever)
Alpha-gal Syndrome (AGS) Clinical Protocol
Diagnostic Criteria
- Delayed reaction window: Symptoms appear 3–8 hours after ingestion of mammalian meat or products (due to metabolic clearance timeline of lipid-bound carbohydrates — distinguishes AGS from immediate IgE food allergy)
- Symptom profile: Urticaria, angioedema, severe abdominal cramping, vomiting, diarrhea, or full systemic anaphylaxis
- Lab: Serum Alpha-gal specific IgE (sIgE) blood test — value >0.1 IU/mL positive when aligned with clinical history
- Skin prick limitation: Traditional skin-prick tests with raw meats frequently yield false negatives — serum sIgE testing is the preferred diagnostic modality
Long-Term Management
- Primary avoidance: Strict elimination of mammalian meat (beef, pork, lamb, venison, bison). Poultry and seafood are safe.
- Sensitivity-dependent secondary avoidance: Dairy products, gelatin-containing foods (marshmallows, gummies, gelcaps/medication capsules), lard — based on individual sIgE titer and reaction history
- Emergency preparedness: Always prescribe and instruct on epinephrine auto-injector use (EpiPen or equivalent)
- Prognosis: Subsequent Lone Star tick bites will spike sIgE levels and worsen sensitivity. Strict long-term avoidance of further bites can allow titers to naturally decline over several years.
Emerging Tick-Borne Viruses
Powassan Virus (Flavivirus)
Heartland & Bourbon Viruses
Critical Diagnostic Pitfalls
Seronegative Window — Lyme Disease
Standard two-tier serology (ELISA + Western Blot) takes 2–6 weeks post-bite for IgM and IgG to reach detectable levels. Early localized Lyme with an erythema migrans rash must be diagnosed and treated clinically — waiting for laboratory confirmation yields high false-negative rates and delays treatment during the most treatable window.
Antibiotic Interruption of Seroconversion
Initiating doxycycline early can blunt the immune response, causing patients to remain seronegative on subsequent Western Blot testing even when infection was present. A negative follow-up serology in a clinically treated patient is not reliable evidence of absence of infection.
Tick Testing Limitations
The CDC explicitly discourages using commercial tick PCR testing to guide clinical decisions. Pathogen presence in the tick does not guarantee transmission occurred; a negative test does not rule out infection from concurrent unknown bites. Treatment must be guided by patient symptomatology and epidemiological exposure history — not tick test results.
Rickettsial Cross-Reactivity on IFA Testing
IFA testing for RMSF (Rickettsia rickettsii) exhibits significant cross-reactivity with other spotted-fever group rickettsiae (e.g., Rickettsia parkeri, R. amblyommatis), which cause less severe illness. Definitive species-level diagnosis may be challenging serologically. Treatment protocols and urgency remain identical regardless of the specific rickettsial species.
Post-Bite Action Plan
Step 1 — Mechanical Removal
Use fine-tipped tweezers. Grasp the tick's mouthparts as close to the skin surface as possible. Pull upward with steady, even pressure — do not jerk or twist. Do not squeeze the tick's body. Do not apply heat, petroleum jelly, nail polish, or any chemical — these methods are ineffective and may increase pathogen transmission risk.
Step 2 — Wound Disinfection
Clean the bite site immediately with soap and water, rubbing alcohol (isopropyl 70%+), or iodine scrub. Dispose of the tick by placing in sealed container, submersing in alcohol, or flushing down the toilet.
Lyme Disease Prophylaxis — Single-Dose Doxycycline 200 mg PO
Prophylaxis is indicated when ALL of the following criteria are met:
- Tick reliably identified as adult or nymphal Ixodes scapularis (Blacklegged tick)
- Estimated attachment duration ≥ 36 hours (based on degree of engorgement or credible exposure timeline)
- Local ecological infection rate of B. burgdorferi in host ticks is ≥ 20% (applies to highly endemic Northeast and Upper Midwest regions)
- Prophylaxis can be started within 72 hours of tick removal
- No contraindications to doxycycline (pregnancy, age <8 years)